Send me a link:

*Text messaging rates may apply.

 Dow Up 0.04% Nasdaq Up 0.12%

ArQule Inc. (ARQL)

-NasdaqGM
1.41 Down 0.03(2.08%) 12:42PM EDT - Nasdaq Real Time Price
Prev Close:1.44
Open:1.44
Bid:1.41 x 5100
Ask:1.42 x 1800
1y Target Est:3.25
Beta:1.27
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:1.40 - 1.44
52wk Range:1.29 - 2.94
Volume:56,013
Avg Vol (3m):728,516
Market Cap:88.44M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARQLDown 2.08%88.44M
ARRYDown 3.22%530.39M
ASTX 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.49
Quarterly EPS Est (Jun-14) :-0.12
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-0.57

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ArQule, Inc., a clinical-stage biotechnology company, researches and develops cancer therapeutics. Its lead product candidate tivantinib is an inhibitor of the c-Met receptor tyrosine kinase and its biological pathway, which is in Phase 3 clinical... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback